Summary

North America Contrast Media Injectors Market Summary

The North America contrast media injectors market size was estimated at USD 809.36 million in 2024 and is projected to reach USD 1,828.90 million by 2033, growing at a CAGR of 9.69% from 2025 to 2033. The demand for contrast media injectors in North America is increasing due to the rising need for imaging tests such as MRI, CT scans, and angiography, along with the growing adoption of advanced technologies like syringeless injectors.

The growing demand for medical imaging in the U.S. and Canada is driving market growth. Data from the Canadian Medical Imaging Inventory (CMII) report indicates that approximately 6,385,665 CT exams were conducted, averaging 160.2 exams per 1,000 people in Canada in 2022-2023. This high volume of imaging procedures is expected to increase the demand for contrast media injectors in the coming years.

Furthermore, the increasing prevalence of chronic diseases such as cancer and heart disease is expected to significantly drive the growth of the North America contrast media injectors industry. According to the National Library of Medicine, in May 2025, the prevalence of CAD among adults living in the U.S. rose from 4.6% to 4.9% within 3 years till 2022, indicating a growing patient population requiring advanced cardiovascular imaging.

Similarly, cancer incidence in Canada is significantly increasing. According to data published by the Canadian Medical Association Journal, approximately 247,100 new cancer cases are projected for Canada in 2024. This rising disease burden is increasing the demand for precise and efficient diagnostic imaging techniques such as CT scans and MRIs, which rely heavily on contrast media injectors to enhance image clarity. As a result, healthcare providers across North America are investing in innovative contrast injector systems to improve diagnostic accuracy and patient outcomes, fueling market expansion.

North America Contrast Media Injectors Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America contrast media injectors market report based on product, type, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Injector systems
o CT injector systems
o MRI injector systems
o Cardiovascular/angiography injector systems
• Consumables
o Syringes
o Tubings
o Others
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Single-head injectors
• Dual head injectors
• Syringeless injectors
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Radiology
• Interventional cardiology
• Interventional radiology
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostics centers
• Ambulatory surgery centers
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Type
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. North America Contrast Media Injectors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for imaging tests
3.2.1.2. Rising launches and approvals of contrast media injectors
3.2.1.3. Increasing prevalence of chronic disorders
3.2.1.4. Growing adoption of syringeless injectors
3.2.2. Market restraint analysis
3.2.2.1. Potential complications and risks associated with contrast media injections
3.2.3. Market opportunity analysis
3.2.3.1. Rising number of distribution agreements
3.2.3.2. Advancements in contrast media injectors
3.2.3.3. Growing clinical trials for contrast media and injectors
3.2.4. Market challenge analysis
3.2.4.1. Shortage of radiologists and healthcare professionals
3.3. North America Contrast Media Injectors Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. North America Contrast Media Injectors Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. North America Contrast Media Injectors Market Product Movement Analysis
4.3. North America Contrast Media Injectors Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Injector systems
4.4.1. Injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.1. CT injector systems
4.4.1.1.1. CT injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.2. MRI injector systems
4.4.1.2.1. MRI injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.3. Cardiovascular/angiography injector systems
4.4.1.3.1. Cardiovascular/angiography injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
4.5. Consumables
4.5.1. Consumables market estimates and forecasts for 2021 to 2033 (USD Million)
4.5.1.1. Syringes
4.5.1.1.1. Syringes market estimates and forecasts for 2021 to 2033 (USD Million)
4.5.1.2. Tubings
4.5.1.2.1. Tubings market estimates and forecasts for 2021 to 2033 (USD Million)
4.5.1.3. Others
4.5.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 5. North America Contrast Media Injectors Market: Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. North America Contrast Media Injectors Market Type Movement Analysis
5.3. North America Contrast Media Injectors Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
5.4. Single head injectors
5.4.1. Single head injectors market estimates and forecasts for 2021 to 2033 (USD Million)
5.5. Dual head injectors
5.5.1. Dual head injectors market estimates and forecasts for 2021 to 2033 (USD Million)
5.6. Syringeless injectors
5.6.1. Syringeless injectors market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 6. North America Contrast Media Injectors Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. North America Contrast Media Injectors Market Application Movement Analysis
6.3. North America Contrast Media Injectors Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Radiology
6.4.1. Radiology market estimates and forecasts for 2021 to 2033 (USD Million)
6.5. Interventional cardiology
6.5.1. Interventional cardiology market estimates and forecasts for 2021 to 2033 (USD Million)
6.6. Interventional radiology
6.6.1. Interventional radiology market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 7. North America Contrast Media Injectors Devices: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. North America Contrast Media Injectors Market End Use Movement Analysis
7.3. North America Contrast Media Injectors Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospitals
7.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
7.5. Diagnostics centers
7.5.1. Diagnostics centers market estimates and forecasts for 2021 to 2033 (USD Million)
7.6. Ambulatory Surgery Centers
7.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 8. North America Contrast Media Injectors Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
8.3. North America
8.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Key country dynamics
8.3.2.2. Competitive scenario
8.3.2.3. Regulatory framework
8.3.2.4. Reimbursement scenario
8.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
8.3.3. Canada
8.3.3.1. Key country dynamics
8.3.3.2. Competitive scenario
8.3.3.3. Regulatory framework
8.3.3.4. Reimbursement scenario
8.3.3.5. Canada market estimates and forecasts, 2021 - 2033
8.3.4. Mexico
8.3.4.1. Key country dynamics
8.3.4.2. Competitive scenario
8.3.4.3. Regulatory framework
8.3.4.4. Reimbursement scenario
8.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2024
9.3.4. Bracco Diagnostics Inc.
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Shenzhen Boon Medical Supply Co., Ltd.
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Bayer Corporation
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Guerbet LLC
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. B. Braun Medical Inc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. ulrich GmbH & Co. KG,
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Shenzhen Antmed Co., Ltd.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Ecomed Solutions
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Siemens Medical Solutions USA, Inc
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.4. Heat Map Analysis/ Company Market Position Analysis
9.5. Estimated Company Market Share Analysis, 2024
9.6. List of Other Key Market Players